How can we develop universal H5N1 vaccines.

about

How can we develop universal H5N1 vaccines.

Item

http://www.wikidata.org/entity/Q50948360

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

How can we develop universal H5N1 vaccines.

@en

How can we develop universal H5N1 vaccines.

@nl

type

Item

label

How can we develop universal H5N1 vaccines.

@en

How can we develop universal H5N1 vaccines.

@nl

prefLabel

How can we develop universal H5N1 vaccines.

@en

How can we develop universal H5N1 vaccines.

@nl

P1476

How can we develop universal H5N1 vaccines.

@en

P2093

Fang He

http://www.w3.org/2001/XMLSchema#string

Jimmy Kwang

http://www.w3.org/2001/XMLSchema#string

Yunrui Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.

Epitope-based approaches to a universal influenza vaccine.

Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.

Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus

Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines.

Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.

P304

713-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/IMT.15.42

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26250411

http://www.w3.org/2001/XMLSchema#string